Decisions
Legal principleProblem-solution approach is not mandatory under EPC/UPCA but may be applied as a cross-checkClear all
| Date | Case | Division | Action | Motion | Outcome | Summary |
|---|---|---|---|---|---|---|
| 2024-07-19 | CC_584916/2023 | Paris CD | Counterclaim for revocation | Revocation merits | Patent amended | The Central Division (Paris) maintained Edwards Lifesciences' EP 3 646 825 (prosthetic heart valve) in amended form (Auxiliary Request II) following revocation actions and counterclaims by Meril entities. All invalidity grounds against the amended claims were rejected. |